Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Divi's Laboratories Limited
  6. Summary
    DIVISLAB   INE361B01024

DIVI'S LABORATORIES LIMITED

(DIVISLAB)
  Report
Delayed NSE India Stock Exchange  -  07:29 2022-10-06 am EDT
3733.00 INR   -1.25%
09/23Indian Benchmarks Drop Nearly 2%; Power Grid Corp. of India Slumps 8%
MT
09/23INDIA STOCKS-Indian shares fall nearly 2% on fears of foreign funds outflow
RE
08/25Indian Indices End on Negative Note on Thursday; Adani Ports Drops 2%
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
09/29/2022 09/30/2022 10/03/2022 10/04/2022 10/06/2022 Date
3693.65(c) 3705.2(c) 3726.85(c) 3780.1(c) 3733(c) Last
795 614 433 624 549 563 287 021 354 601 Volume
-0.26% +0.31% +0.58% +1.43% -1.25% Change
More quotes
Estimated financial data (e)
Sales 2023 90 248 M 1 099 M 1 099 M
Net income 2023 25 652 M 312 M 312 M
Net cash position 2023 37 729 M 460 M 460 M
P/E ratio 2023 39,1x
Yield 2023 0,76%
Sales 2024 101 B 1 234 M 1 234 M
Net income 2024 29 208 M 356 M 356 M
Net cash position 2024 47 448 M 578 M 578 M
P/E ratio 2024 34,0x
Yield 2024 0,81%
Capitalization 991 B 12 071 M 12 071 M
EV / Sales 2023 10,6x
EV / Sales 2024 9,31x
Nbr of Employees 16 543
Free-Float 47,6%
More Financials
Company
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India. 
Sector
Pharmaceuticals
Calendar
11/03Earnings Release
More about the company
Ratings of Divi's Laboratories Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about DIVI'S LABORATORIES LIMITED
09/23Indian Benchmarks Drop Nearly 2%; Power Grid Corp. of India Slumps 8%
MT
09/23INDIA STOCKS-Indian shares fall nearly 2% on fears of foreign funds outflow
RE
08/25Indian Indices End on Negative Note on Thursday; Adani Ports Drops 2%
MT
08/24Indian Indices End Flat on Wednesday; Apollo Hospitals Enterprise Top Gainers
MT
08/24Indian shares flat in volatile trade, IT weakens
RE
08/23Indian Indices Snap Two-Day Losing Run on Tuesday; Mahindra & Mahindra Jumps 4%
MT
08/15Divi's Laboratories Reports Rise in Fiscal Q1 Consolidated Net Profit
MT
08/12Indian Indices Close Week in Green; Oil & Natural Gas Corp. Jumps 5%
MT
08/12Transcript : Divi's Laboratories Limited, Q1 2023 Earnings Call, Aug 12, 2022
CI
08/12Divi's Laboratories Limited Reports Earnings Results for the First Quarter Ended June 3..
CI
08/11DIVI'S LABORATORIES LIMITED : Ex-dividend day for final divi..
FA
07/27Indian Indices Close 1% Higher; Sun Pharmaceutical Industries Climbs 3%
MT
07/13Indian Indices Close Lower Midweek; IndusInd Bank Slumps 3%
MT
07/05Divi's Laboratories Limited Recommends Dividend
CI
05/26Indian Indices Settle in Green Zone; Tata Steel Jumps 5%
MT
More news
News in other languages on DIVI'S LABORATORIES LIMITED
09/23STOCKS INDE - Les actions indiennes chutent de près de 2 % en raison des craintes de so..
08/25Les indices indiens terminent sur une note négative jeudi ; Adani Ports chute de 2%.
08/24Les indices indiens terminent à plat mercredi ; l'entreprise Apollo Hospitals en tête d..
08/24Les actions indiennes stagnent dans un commerce volatile, les TI faiblissent
08/23Les indices indiens rompent leur série de pertes de deux jours mardi ; Mahindra & Mahin..
More news
ETFs positioned on DIVI'S LABORATORIES LIMITEDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
VanEck Vectors India Growth Leaders ETF - USD5.06%2.96%-India
KraneShares Emerging Market Healthcare Inde...2.54%2.77%NC
Nippon India ETF Shariah BeES - INR2.36%1.94%-India
First Trust India NIFTY 50 Equal Weight ETF - USD1.94%3.02%World
IShares MSCI India ETF - USD0.8%0.63%India
More ETFs positioned on DIVI'S LABORATORIES LIMITED
Chart DIVI'S LABORATORIES LIMITED
Duration : Period :
Divi's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DIVI'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 3 733,00 INR
Average target price 4 115,74 INR
Spread / Average Target 10,3%
EPS Revisions
Managers and Directors
Satchandra Kiran Divi Chief Executive Officer & Executive Director
L. Kishore Babu Chief Financial Officer
Ramesh B. V. Nimmagadda Non-Executive Chairman
L. Ramesh Babu Chief Information Officer & VP-Procurement
Ramesh Babu M. Chief Technologist
Sector and Competitors
1st jan.Capi. (M$)
DIVI'S LABORATORIES LIMITED-19.20%12 288
JOHNSON & JOHNSON-3.48%434 104
ELI LILLY AND COMPANY19.43%315 249
ROCHE HOLDING AG-13.48%273 724
ABBVIE INC.5.86%253 421
PFIZER, INC.-25.28%247 617